Evaluation of X chromosome inactivation with respect to HLA genetic susceptibility in rheumatoid arthritis and systemic sclerosis

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Kanaan, Sami B ^a,b   Onat, Onur E ^c   Balandraud, Nathalie ^a,d   Martin, Gabriel V ^a,b   Nelson, J Lee ^e,f   Azzouz, Doua F ^a,b   Auger, Isabelle ^a,b   Arnoux, Fanny ^a,b   Martin, Marielle ^a,b   Roudier, Jean ^a,b,d   Ozcelik, Tayfun ^c   Lambert, Nathalie C ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c BILKENT UNIVERSITY   (Turkey)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e USA   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; AUTOANTIBODY; HLA ANTIGEN; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; AUTOIMMUNITY; CHROMOSOME MOSAICISM; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA DQB1 GENE; HLA DRB1 GENE; HUMAN; MAJOR CLINICAL STUDY; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS; X CHROMOSOME INACTIVATION; BLOOD; CASE CONTROL STUDY; CYTOLOGY; DNA METHYLATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; RECEPTORS, ANDROGEN; SCLERODERMA, SYSTEMIC; X CHROMOSOME INACTIVATION;

EID: 84977272708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158550     Document Type: Article

References (38)

1. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmunity reviews. 2008; 7(8):626-30. doi: 10.1016/j.autrev.2008.06.009 PMID: 18603021.
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997; 84(3):223-43. Epub 1997/09/01. S0090122997944123 [pii]. PMID: 9281381.
3. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010; 37(1):42-53. Epub 2010/02/24. doi: 10.1111/j.1346-8138.2009.00762.xJDE762 [pii]. PMID: 20175839.
4. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006; 65(7):845-51. Epub 2006/04/12. [pii] doi: 10.1136/ard.2006.051391 PMID: 16606649; PubMed Central PMCID: PMC1798205.
5. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003; 48(10):2741-9. Epub 2003/10/15. doi: 10.1002/art.11223 PMID: 14558078.
6. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol. 1991; 18(9):1282-4. Epub 1991/09/01. PMID: 1757925.
7. Balandraud N, Picard C, Reviron D, Landais C, Toussirot E, Lambert N, et al. HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis. PLoS One. 2013; 8(5):e64108. Epub 2013/06/06. doi: 10.1371/journal.pone.0064108PONE-D-12-38379 [pii]. PMID: 23737967; PubMed Central PMCID: PMC3667843.
8. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987; 30(11):1205-13. Epub 1987/11/01. PMID: 2446635.
9. Azzouz DF, Rak JM, Fajardy I, Allanore Y, Tiev KP, Farge-Bancel D, et al. Comparing HLA shared epitopes in French Caucasian patients with scleroderma. PloS one. 2012; 7(5):e36870. Epub 2012/05/23. doi: 10.1371/journal.pone.0036870 PMID: 22615829; PubMed Central PMCID: PMC3352938.
10. Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Annals of the rheumatic diseases. 2010; 69(5):822-7. Epub 2009/07/15. [pii] doi: 10.1136/ard.2009.111906 PMID: 19596691; PubMed Central PMCID: PMC2916702.
11. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest. 1993; 92(3):1296-301. Epub 1993/09/01. doi: 10.1172/JCI116703 PMID: 7690776; PubMed Central PMCID: PMC288271.
12. Reveille JD, Durban E, MacLeod-St Clair MJ, Goldstein R, Moreda R, Altman RD, et al. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest. 1992; 90(3):973-80. Epub 1992/09/01. doi: 10.1172/JCI115974 PMID: 1326003; PubMed Central PMCID: PMC329953.
13. Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 2005; 52(5):1564-70. Epub 2005/05/10. doi: 10.1002/art.21026 PMID: 15880831.
14. Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Orstavik KH, Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab. 2005; 90(11):5949-53. Epub 2005/08/18. [pii] doi: 10.1210/jc.2005-1366 PMID: 16105963.
15. Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A, et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet. 2006; 14(6):791-7. Epub 2006/04/06. [pii] doi: 10.1038/sj.ejhg.5201614 PMID: 16596118.
16. Uz E, Loubiere LS, Gadi VK, Ozbalkan Z, Stewart J, Nelson JL, et al. Skewed X-chromosome inactivation in scleroderma. Clinical reviews in allergy & immunology. 2008; 34(3):352-5.
17. Chabchoub G, Uz E, Maalej A, Mustafa CA, Rebai A, Mnif M, et al. Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther. 2009; 11(4):R106. doi: 10.1186/ar2759 PMID: 19589151
18. Uz E, Mustafa C, Topaloglu R, Bilginer Y, Dursun A, Kasapcopur O, et al. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum. 2009; 60(11):3410-2. Epub 2009/10/31. doi: 10.1002/art.24956 PMID: 19877028.
19. Lee JT. Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nature reviews Molecular cell biology. 2011; 12(12):815-26. doi: 10.1038/nrm3231 PMID: 22108600.
20. Lambert NC. The price of silence. Arthritis Rheum. 2009; 60(11):3164-7. Epub 2009/10/31. doi: 10.1002/art.24962 PMID: 19877071.
21. Brown C, Robinson W. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin Genet. 2000; 58(5):353-63. PMID: 11140834
22. Puck JM, Willard HF. X inactivation in females with X-linked disease. New Engl J Med. 1998; 338(5):325. PMID: 9445416
23. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunology today. 1998; 19(8):352-7. PMID: 9709502
24. del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA-DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis and rheumatism. 2002; 46(6):1480-8. doi: 10.1002/art.10295 PMID: 12115177.
25. Lambert NC, Distler O, Muller-Ladner U, Tylee TS, Furst DE, Nelson JL. HLA-DQA1∗0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis and rheumatism. 2000; 43(9):2005-10. doi: 10.1002/1529-0131(200009)43:9〈2005::AID-ANR11〉3.0.CO;2-# PMID: 11014350.
26. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569-81. Epub 2010/09/28. doi: 10.1002/art.27584 PMID: 20872595.
27. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001; 28(7):1573-6. Epub 2001/07/27. PMID: 11469464.
28. Loubiere LS, Lambert NC, Madeleine MM, Porter AJ, Mullarkey ME, Pang JM, et al. HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women. Rheumatology. 2005; 44(3):318-22. doi: 10.1093/rheumatology/keh489 PMID: 15572392.
29. Vollmann J, Winau R. Informed consent in human experimentation before the Nuremberg code. BMJ. 1996; 313(7070):1445-9. Epub 1996/12/07. PMID: 8973233; PubMed Central PMCID: PMC2352998.
30. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992; 51(6):1229-39. Epub 1992/12/01. PMID: 1281384; PubMed Central PMCID: PMC1682906.
31. Delforge M, Demuynck H, Vandenberghe P, Verhoef G, Zachee P, van Duppen V, et al. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood. 1995; 86(10):3660-7. Epub 1995/11/15. PMID: 7579331.
32. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in rx c contingency tables. J Am Stat Assoc. 1983; 78(382):427-34.
33. Amos-Landgraf JM, Cottle A, Plenge RM, Friez M, Schwartz CE, Longshore J, et al. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet. 2006; 79(3):493-9. Epub 2006/08/16. S0002-9297(07)62748-7 [pii] doi: 10.1086/507565 PMID: 16909387; PubMed Central PMCID: PMC1559535.
34. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med. 1992; 117(10):801-6. PMID: 1416553
35. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1∗ 0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol. 1995; 22(6):1032-6. PMID: 7674226
36. Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis. 2006; 65(7):905-9. PMID: 16284099
37. Broen JC, Wolvers-Tettero IL, Geurts-van Bon L, Vonk MC, Coenen MJ, Lafyatis R, et al. Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis. Ann Rheum Dis. 2010; 69(12):2213-6. doi: 10.1136/ard.2010.129999 PMID: 20699236
38. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis and rheumatism. 1994; 37(1):75-83. PMID: 8129766.